Identifying and Overcoming Perceived Barriers of Providers towards HPV Vaccination: A Literature Review

Table 1

Vaccine	Indications	HPV types	Contraindication	Efficacy
Cervarix/2vHPV (Merck)	Cervical precancer and cancer	16 and 18	Latex hypersensitivity	92.9%
Gardasil/4vHPV (GlaxoSmithKline)	Cervical cancers; Cervical, vaginal, vulvar, and anal cancers and genital warts	6, 11, 16, 18	Yeast hypersensitivity	98–100%
Gardasil 9/9vHPV (Merck)	Cervical, vaginal, vulvar, and anal cancers and genital warts	6, 11, 16, 18; 31, 33, 45, 52, 58		96.3–96.7%